Assessments and parameters | Descriptions | |
---|---|---|
Subjective assessments of well-being | ||
Validated questionnaires useful to assess quality of life and gut health | IBS-Quality of Life (IBS-QOL) | Validated for assessment of quality of life specific to IBS: 34 questions |
 | Inflammatory Bowel Disease Questionnaire (IBDQ) | Validated for assessment of health-related quality of life (HRQoL) in adult patients with IBD |
 | Bowel Disease Questionnaire (BDQ) | Validated to distinguish patients with functional and organic GI disease |
 | Health Status Questionnaire (HSQ-12) | Validated for assessment of HRQoL in the general population |
 | Short Form Health Survey SF-12 (SF-12) | Validated for assessment of HRQoL in the general population |
GI symptom scores | IBS Severity Scoring System (IBS-SSS) | Validated for scoring lower GI symptoms on the basis of nine questions; range of 0 to 500 points |
 | Short Form Leeds Dyspepsia Questionnaire (SF-LDQ) | Validated instrument for measuring the presence and severity of dyspepsia |
 | Gastrointestinal Symptom (GIS) profile | Validated for assessment of symptoms of functional dyspepsia; 10 questions |
 | Subject's Global Assessment of Relief (SGA) | Validated assessment of the impact of treatment on IBS-related symptoms; 1 question |
 | IBS Global Assessment of Improvement (IBS-GAI) ("adequate relief") | Asks participants if, compared to the way they felt before entering the study, their IBS symptoms have changed over the past 7 days; 1 question |
 | Functional Bowel Disorder Severity Index (FBDSI) | Validated score for assessment of patient perception of abdominal pain in IBS |
 | Numeric Rating Scale (NRS) for assessment of pain | Validated in IBS patients |
 | Visceral Sensitivity Index (VSI) | Validated psychometric instrument that measures GI symptom-specific anxiety |
 | Bristol Stool Scale/Bristol Stool Chart | A medical aid designed to classify the form of human faeces into seven categories |
 | Gastrointestinal Symptom Rating Scale |  |
Eating habits | Food frequency questionnaire | 7-day diet history assessed using computer software |
Objective parameters | ||
Markers of functionality | Gastric function | pH metry in the esophagus [6, 7] and stomach [1–3], gastroesophageal reflux episodes (< 50/day, <60 minutes total), viscosity of the luminal content using a viscometer, stool weight (> 100 g/d, <500 g/d) and stool consistency (water content) |
 | Permeability measurements | Tracer molecules (lactulose/mannitol, 51Cr-EDTA, PEG); |
 | Motility tests | Barostat, gastric scintigraphy, 13C urea breath test (gastric emptying) and lactulose hydrogen breath test (normal range: 40 to 240 hours) |
 | Transit time | Radiopaque pellets (Hinton test) and isotope-labelled test meal (normal range: 24 to 168 hours) |
 | Digestion parameters | Stool elastase (> 200/g) and stool fat (< 7 g/d), carbohydrate breath tests, anthropometry and micronutrient analysis |
Markers of intestinal integrity | Epithelial integrity | Histology (villus height/crypt depth ratio, mitosis and apoptosis), mucus secretion (mucins and trefoil peptides) and Ussing chamber (ion fluxes and electric potentials) |
 | Specific molecules | E-cadherin, growth factors, tight junction molecules, α1-antitrypsin in faeces and LPS in blood |
 | Antimicrobial peptides | α- and β-defensins, calprotectin, lysozyme or neutrophil-derived elastase in faeces |
Marker of intact immunity | Cell counts and phenotyping | Differential blood count and FACS analysis, histopathology of intestinal biopsies and immunohistochemistry of intestinal biopsies |
 | Cell mediators and cytokines | Inflammatory cytokines (IL-1, IL-6 and TNFα), anti-inflammatory cytokines (IL-10 and TGFβ), regulatory cytokines (IL-2, sIL-2R, IL-4, IL-5 and so on), proteases (tryptase, chymases, chymotrypsin and so on), immunoglobulins (IgA, sIgA and IgE) and others (retinoic acid, neuropeptides and so on) |
 | Functional assays | Cell cultures and cocultures, DTH response, phagocytosis, chemotaxis, oxidative burst (superoxide anion generation) and NK cell activity |
Analysis of the intestinal microbiome | Classical approaches | Bacterial culture and toxin measurements |
 | New approaches | Metagenomics (PCR and full bacterial sequencing), metabonomics (metabolic capacity of the microbiome) |